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The prion protein (PrP) is a naturally occurring protein found at high levels in central nervous 
system (CNS). The misfolding of the PrP is responsible for neurodegenerative diseases called 
transmissible spongioform encephalopathies (TSE) that include mad cow disease, scrapie in 
sheep and goats, kuru and Creutzfelt-Jakob disease (CJD) in humans. The normal function of the 
PrP is still unknown but demonstrates high selectivity for copper (Cu+2). The mature form of PrP 
consists of a highly unstructured N-terminal region (23-124). The copper binding region spans 
from residues 60 to 96 and contains four octarepeat segments, PHGGGWGQ, and a GGGTH 
segment. When fully copper loaded, each octarepeat binds to a copper and the fifth copper 
binding involves the GGGTH site. Although the molecular details of a fully Cu+2 loaded state are 
well understood, very little is known about the low copper binding state of PrP. At low 
Cu+2occupancy there is a possibility of PrP cross-linking. This project aims at obtaining the 
thermodynamic profile of the prion copper complex at low copper loading state to determine the 
forces that drive the complex formation. The model peptides were generated using solid phase 
  
 
 
peptide synthesis; the thermodynamic studies were done using isothermal titration calorimetry 
(ITC) and supporting spectroscopic studies by circular dichroism (CD). Examination of the ITC 
titration data suggests an initial binding event where two PrP’s are cross-linked by a single 
copper ion. ITC titrations were performed in both forward and reverse directions in order to 
examine the reversibility of the copper binding process. Fitting the ITC data with the existing 
models, i.e one sets of sites, two sets of sites or sequential binding, lead to unsatisfactory fits 
suggesting a more complex binding process. The hypothesized binding model will hopefully lead 
to good fits for the ITC data and will support the hypothesis that Cu+2 is cross- linking PrP 
molecules at low equivalents of added Cu+2 . 
 
 
 
 
 
 
 
 
 
 
 
 
Figure representing the PrP cross linking at low copper loadings 
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Chapter 1: Introduction 
 
1.1 Overview of Prion Protein and Prion Disease 
 In the late 20th century, certain infectious particles were found to be responsible for a 
unique class of diseases. These infectious particles were first identified to cause fatal 
neurodegenerative diseases characterized by loss of motor control, dementia and paralysis in 
sheep and goats1, 2.These particles were named Prions, by Stanley B. Prusiner referring to 
“proteineous infectious particles”. They are caused by deposits of misfolded aggregates of a 
protein which has novel properties of transmitting the disease in spite of the absence of nucleic 
acids3. The prion diseases include mad cow disease in bovine species, scrapie in sheep and goat, 
and chronic wasting disease in deer and elk. All the diseases caused by the prion protein were 
collectively called transmissible spongioform encephalopathies (TSEs). Statistically, TSE’s are 
rare in humans. Some cases of kuru, Creutzfeldt- Jakob’s disease (CJD), new variant CJD were 
seen in humans. Mainly due to their mode of transmission prions are considered as a threat and 
might lead to a widespread outbreak. This nature of the Prion Protein (PrP) still holds interest in 
this field of research. The normal cellular functional PrP is represented as PrPc which undergoes 
a conformational change to form PrPSc. This could be spontaneous, sporadic or inherited. 
Sporadic TSEs are most common where PrPSc is formed spontaneously. PrPSc, the scrapie form is 
the misfolded protein with β sheet formation. Due to its amyloidogenic nature, it forms 
aggregates destroying neighboring neurons. The unique feature of this form is its mode of 
replication. A PrPSc once formed acts as a template and converts all the nearby healthy normal 
PrPc into misfolded forms (PrPSc) though it is devoid of nucleic acids. This ultimately results in 
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neurodegeneration. Research into the function and mechanism of action of misfolding will 
provide insight into treatment of these diseases.  
 PrP is an endogenous protein commonly found in many body tissues. It is present at high 
levels in the Central Nervous System. The C-terminal region of the PrP is tethered to the outer 
surface of the cells through a Glycosylphosphatidylinositol (GPI) anchor3. The mature form of 
the human PrP consists of 208 amino acids. NMR studies conducted on PrP revealed that the C-
terminal region of PrP (125-230) has globular structure comprised largely of alpha helices and 
two stranded antiparallel β sheet. The N-terminal of the protein was found to be unstructured (23 
-124)4-7. So, PrP is categorized as natively unfolded protein5, 8.  
 
 
 
Figure 1.1: Structure of full length PrP obtained by NMR studies4. 
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 Despite the tremendous research on PrP, its normal function remains unclear. Several 
experiments were done on PrP knockout mice to determine its function. No remarkable change 
was observed in the knockout mice making it evident that PrP has a redundant function9. It was 
also observed that the brain extracts of the knockout mice showed lower copper content implying 
that PrP could probably influence the copper tissue content10. The identification of PrP as a 
copper binding protein led to a majority of the hypotheses on its normal cellular functions. Also, 
PrP undergoes endocytosis in the presence of Cu+2 and Zn+2. Upon exposure to these metals, the 
PrP anchored to the cell surface is drawn into an endosome into the interior of the cell and then 
cycled back to the surface of the cell11-13. This led to the speculation that PrP might be involved 
in transporting and storing Cu+2 ions thus participating in copper homeostasis. Alternatively, it is 
also argued that PrP is involved in antioxidant activity due to its capacity to dismutase 
superoxide and detoxify O2- 14.             
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1.2 Structural Details of the Prion Protein and Copper Binding 
 As mentioned earlier in the chapter, NMR studies on the recombinant form of PrP 
revealed that the mature form of human PrP (23-230) consists of a highly globular C-terminus 
(125-230) with three alpha helices and two antiparallel β sheets. The N-terminus (23-124) lacks 
any detectable secondary structure. The flexible N- terminus contains four repeats of octapeptide 
sequence PHGGGWGQ (60-91)15 followed by GGGTH (92-96) as shown below. 
 
WGQ(PHGGGWGQ)4GGGTHNQ 
 
 The number of octarepeats may vary between species but it is the highly conserved 
portion of PrP sequence15. It was observed that peptide constructs devoid of the octarepeat region 
do not undergo endocytosis that is stimulated by Cu+2 16. PrP binding to copper in vivo provides 
good evidence that it is a copper binding protein. Thus, PrP has been identified as a copper 
binding protein17, 18.                      
 The metal binding region of PrP resides in the flexible N-terminal domain as most of the 
copper dependent responses measured are clearly linked to this region17, 18. Hence, the N- 
terminal region is of great interest. The N-terminal region is highly selective to Cu+2 with Kd‘s 
ranging from low micromolar to nanomolar range19, 20. Thus, PrP has a lot of competition for 
Cu+2 under physiological conditions.      
 Mass spectrometry and several other studies using different techniques have revealed that 
at a pH of 7.4 PrP is capable of binding up to five copper ions 19. Figure 1.3 represents a PrP 
loaded with five coppers. Cu+2 binding to PrP is pH dependent. At a pH of 6, it binds to only two 
Coppers19. 
  
5 
 
 
 
Figure 1.2 Location of the five main copper binding sites of PrP. Spheres represent Cu+2 ions24. 
 
 When the octarepeat domain is fully Cu+2–loaded each octarepeat binds a single Cu+2 
ion21. Studies involving electron paramagnetic resonance spectroscopy (ESR or EPR) and X-ray 
crystallography show that the pentapeptide segment HGGGW constitutes the minimum Cu+2 
binding unit as shown in Figure 1.4 22,23.                                
 
 
Figure 1.3 Bond line model of the HGGGW-Cu+2complex24 
 
 The ligands involved in the coordination complex are the nitrogen from the histidine 
imidazole ring, deprotonated amides from the following two Glycine residues and carbonyl 
  
6 
 
oxygen from the second Glycine in square planar arrangement. A line-bond structure was 
proposed based on EPR and X-ray crystallography data23. 
 
 
 
Figure 1.4 Crystal Structure Model of HGGGW- Cu+2 complex23. 
 
 The crystal structure represented in the figure 1.4 also reveals axial coordination to a 
water molecule which participates in hydrogen bond with the indole ring of the tryptophan. 
 As discussed earlier mass spectrometry data revealed that a fully loaded PrP binds five 
coppers. If four octarepeats binds to a copper each that accounts for four coppers, further studies 
were done on full PrP to reveal another copper binding site.  Based on studies on recombinant 
PrP the fifth binding site composed of residues GTH (94-96) was proposed24, 25. 
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                          Figure 1.5: Line-bond model for the fifth binding site in PrP24. 
 
As indicated in the above figure the imidazole ring from the histidine and deprotonated amides 
from histidine, threonine and glycine contribute the nitrogen ligands24. 
 Although PrP is capable of binding up to five coppers, the copper coordination 
environment at low Cu+2 loadings is different from that at high Cu+2 loadings. Later research 
focused on the determining the identity of multiple coordinating complexes possible at sub 
loaded states. EPR signals were monitored during the titration at various concentrations of Cu+2 
to determine the various binding modes that exist during titration 26, 27. 
 
Figure 1.6: Line-bond structure of component 1 of Millhauser’s proposed binding model26. 
  
8 
 
  
The first binding mode, component 1 as shown above in Figure 1.6, occurs in a fully loaded state 
of the protein as discussed earlier.  
 
 
Figure 1.7: Line-bond structure of component 2 of Millhauser’s proposed binding model26. 
 
 The binding mode, component 2, requires two adjacent octarepeats and occurs around 1 
to 2 equivalents. The ligands involved in this component are N-terminal amide of histidine, 
amine of the imidazole ring, and two water molecules. 
 
 
Figure 1.8: Line-bond structure of component 3 of Millhauser’s proposed binding model26. 
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 The other binding component, called component 3, appears at 1 or less equivalents, 
where the amines of the imidazole ring of histidines and a fourth ligand coordinates a single 
copper. 
  All these studies were done on peptide models without the fifth binding site. Figure 1.8 
below shows how the proposed modes of Cu+2 binding influence the overall structure of the 
octarepeat region. Component 1 allows the most dynamic structure as each octarepeat binds a 
single copper. Component 2 allows a semi linear state as two octarepeats bind to a single Cu+2 
and component 3 shows a more globular structure as three octarepeats bind a single Cu+2. 
 
 
Figure 1.9: Proposed models of different binding modes26. 
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1.3 PrP Self-Recognition at Low Cu+2 Loadings 
 One more interesting area is the PrP self recognition at low copper loadings. Work done 
on full length bovine PrP (BoPrP) indicated that the solutions of protein produced increased 
turbidity upon addition of copper. Inspection of the insoluble material by atomic force 
microscopy (AFM) revealed an amorphous mass of PrP- Cu+2complex. Based on these results it 
was concluded that PrP molecules were oriented in a parallel fashion with Cu+2 cross linking 
them28. Further research using Xray absorption spectroscopy on numerous octapeptide models, 
found that a fully Cu+2 loaded BoPrP behaves differently from the half loaded Cu+2 29. At half site 
occupancy, that is 3 equivalents of copper (as bovine species have 5 octarepeats), two histidine 
residues were coordinating a single Cu+2 as shown the figure 1.9.  
       
                          
Figure 1.10: Half site occupancy in BoPrP showing the coordination of a single Cu+2 by two 
octarepeats29. 
 Increasing the Cu+2 /peptide ratio led to rearrangement of the copper coordination sphere, 
where a single histidine bound each copper ion as shown in the figure 2.0. 
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Figure 1.11: Fully loaded Bo PrP representing coordination of a Cu+2 by a single octarepeat29. 
 
  Finally, it was proposed that the coordination of a single Cu+2 by two histidine residues 
from different PrP molecules provides a mechanism for PrP cross linking at low copper 
occupancy (see figure 1.9). These studies were done on peptide models which lacked the fifth 
binding site but the fifth binding site plays an important role in copper binding. The following 
macroscopic mechanism was proposed based on these results. 
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Figure 1.12: Proposed macroscopic process of copper binding in PrP29. 
 
 At very low copper concentration, there are high chances of forming intermolecular 
bonds which rearrange to form intramolecular bonds when the PrP is fully saturated with copper. 
This could be a possible mechanism for PrP- PrP interactions through metal cross-linking. 
 So far a lot of information regarding binding sites and coordination complexes of copper 
has been obtained and most of the research done didn’t involve the fifth binding site. It is 
believed that the last binding site plays an important role in the cooperativity of the entire 
molecule. Research done in our lab indicates that the fifth binding site plays a very important 
role in the early stages of copper uptake. Circular Dichroism (CD) experiments were done on the 
PrP (57-98). CD Spectra of the titration were analyzed using the self-modeling curve resolution 
method multivariate curve resolution–alternating least squares (MCR-ALS). The CD data is 
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discussed in detail in Chapter 4. If the normalized CD intensity is plotted against the equivalents 
(eq.) of copper added a titration plot is obtained as shown in Figure 1.13.  
 
 
Figure 1.13: Integrated CD signal as a function of Cu2+ titrated in PrP peptide in 10 mM NEM at 
pH 7.430 
 The titration is sigmoidal with only small gain in the signal until 1.5 eq. representing a 
CD inactive mode. At low Cu2+ occupancy (<1 eq. of Cu2+), coordination is by multiple 
histidines as shown in Figure 1.7. At intermediate Cu2+ occupancy, there is a competition 
between the multiple histidines and the 5th binding site for Cu2+ and the later saturates first and 
by 5 eq. of Cu2+ all the individual octarepeats are loaded. Thus, the 5th binding site is involved 
early on in the binding process and is saturated before all the individual octarepeats. 
 Some more research done in our lab also indicates that Cu2+ and Zn2+ increase the level 
of PrP- PrP interactions31. Studies were done on PrP models incorporated on the outer surface of 
liposomes through fluorescent lipophilic anchors. On addition of metal, a change in the 
fluorescence signal was observed due to close proximity of the fluorophore in the lipid bilayer as 
0
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shown in the figure 2.3. When close proximity to each other the anchors, pyrene molecules, form 
excimers which have a distinct florescent signal compared to the monomers. 
 
 
Figure 1.14: Illustration of influence of metal on PrP- PrP interaction31. 
     Thus, self recognition of PrP molecules is influenced by the added metals 31. 
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1.4 Project Design 
 The ultimate goal in the field of research involving PrP is to understand the PrP – metal 
binding at a molecular level that might lead to determination of the function of the cellular 
protein and the mechanism of the formation of the aggregates for the hopeful treatment of the 
diseases caused by them. 
 In the present project, we are interested in the thermodynamic aspect of the copper 
binding to the PrP. The objective of this research is to obtain the thermodynamic profile of the 
copper- PrP binding; especially at low copper loadings. Further, it may shed light on the 
advantages of having an unfolded metal binding region. 
 In the direction of the research goal we used Isothermal Titration Calorimetry (ITC) to 
obtain the thermodynamic profile of the binding process. ITC can accurately quantify all the 
thermodynamic properties stoichiometry of the interaction (n), the equilibrium constant (Keq), the 
free energy (∆G), enthalpy (∆H) and entropy of the binding (∆S). 
 Once the thermodynamic contributions of the copper to the PrP are determined from the 
ITC experiments, an understanding of the mechanism and function of the binding at molecular 
level is better understood. Each of the thermodynamic parameters will be explained starting with 
Gibbs free energy (∆G), which gives information about the favorability of the reaction. A 
negative ∆G value termed as exergonic corresponds to a favorable reaction where no work is 
required for the reaction to occur. But in the case of positive ∆G work must be performed from 
the surroundings for the reaction to proceed. It is termed as endergonic and corresponds to a non-
favorable chemical reaction. The ∆G depends on the enthalpy, entropy and the equilibrium 
constant as shown in the equation below. 
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∆G=∆H-T∆S 
∆G=-RTlnK 
 Enthalpy (∆H) is a measure of the total heat involved in a reaction. An exothermic 
reaction results in a negative value for ∆H. A positive value of ∆H is indicative of an 
endothermic reaction. Enthalpy will contribute to the spontaneity of the reaction if it is an 
exothermic reaction. It depends on hydrogen bonding, van der Waals forces, electrostatic 
interactions and π/π interactions. 
 Entropy (∆S) is a measure of energy dispersion at given temperature and is it a function 
of disorder. Increase in disorder of a system is represented by increase in ∆S. The equilibrium 
constant indicates the strength of the binding of the metal to the protein. A larger K value 
corresponds to a more negative ∆G indicating a stronger binding event and a smaller K value 
indicates a weaker binding event. A binding constant greater than 1 indicates a favorable 
reaction. Thus, the thermodynamic data reveal the forces (enthalpic or entropic) that drive the 
complex formation and the mechanism of action. They even provide information on 
conformational changes of proteins, hydrogen bonding, hydrophobic interactions, and charge-
charge interactions. 
 One important aspect of the research goal is determining the thermodynamic profile of 
the PrP copper binding at low copper loadings. Experiments were done earlier on PrP binding, 
but not much information is available on the low copper loading events. ITC being a highly 
sensitive instrument helps us focus on the earlier events or the low copper loading events. Under 
physiological conditions very little copper is available and the concentration is approximated at 
10 µM and during neuronal depolarization around 100 µM20. Hence, PrP needs to compete for 
copper with other biological species some of which have higher affinities. In the competitive 
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environment, copper – prion complex might exist in low copper loadings states. To simulate the 
physiological conditions we chose a highly competing buffer N-2-(Acetamido)-2-aminoethane 
sulfonic acid (ACES). ACES, at the concentration used in the experiments, keeps the copper 
prion complex at low occupancy as discussed in chapter 4. 
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Chapter 2: Synthesis of Peptide Models 
 
2.1 Solid Phase Peptide Synthesis 
 Solid-phase peptide synthesis (SPPS) with 9-fluorenylmethoxycarbonyl (Fmoc) protected 
amino acids was used to synthesize all the peptide models. A linear synthesis strategy was used 
where each amino acid was added one by one until the target peptide is made. It is the most 
straight forward way to perform SPPS. Peptides are synthesized on an insoluble polymeric resin. 
The resin acts as the solid support on which the entire peptide is built. To start the peptide 
synthesis, the resin is deprotected by a secondary amine as shown in the first step of the Figure 
2.1. The deprotecting agent used was 20% piperdine in N, N-dimethylformamide (DMF). 
Removal of the protecting group creates a free amine on the resin which is the reactive group and 
serves as an anchoring site for the addition of the first amino acid. The free carboxyl group of the 
first amino acid reacts with the free amine of the resin to form an amide bond (second step in 
Figure 2.1). The resin has the first amino acid attached while the amine of the amino acid is 
Fmoc protected. It is then deprotected so it can form an amide bond with the free carboxyl group 
of the second amino acid. All the coupling steps are aided by the use of a reagent 
diisopropylethylamine (DIEA). The removal of the Fmoc group and addition of another amino 
acid is repeated until the target peptide is obtained. Thus, in SPPS the peptide chain is 
synthesized from C-terminus to N-terminus. 
 Coupling reagents were used to activate the carboxylic group for attachment to the free 
amine of the growing peptide chain and allow amide bond formation at room temperature.  
O-(benzotriazol-1-yl)-1, 1, 3, 3-tetramethyluronium hexafluorophosphate (HBTU) was used as 
the coupling agent and another reagent 1-hydroxybenzotriazole (HOBt) was used as a catalyst 
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and to prevent any unwanted side reactions. After the last amino acid is attached its free amine is 
acetylated. Once the target peptide is synthesized, it is cleaved from the resin using 
trifluoroacetic acid (TFA), water and triisopropylsilane (TIS). The peptide obtained after 
cleaving has an acetylated N-terminus and amidated C-terminus.  
 
         
Figure 2.1: Deprotection of the Rink Amide MBHA resin and coupling of amino acids. 
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2.2 Synthesis of Peptide Models 
 In the direction of the research goal the first step was to construct the peptide models and 
then, using these models determine the thermodynamic profiles of their binding interaction with 
copper by ITC titrations and complement this data by subsequent CD titrations. 
 Several peptide fragments were synthesized using the principles discussed in chapter 
2.1.The small pentapeptide fragment, HGGGW, was used in the initial ITC and CD studies to  
optimize the experimental parameters though the main peptide of interest was the copper binding 
region restricted to residues 57-98. 
 
                                              WGQ(PHGGGWGQ)4GGGTHNQ  
 
  In the synthesis of this peptide for the copper binding studies a six amino acid stretch, 
KKRPKP (23-28), derived from the N-terminus of PrP was added for increased solubility of the 
overall peptide. It was previously shown to have no effect on the binding of Cu+2. The peptides 
were acetylated at N-terminus and amidated at C-terminus so that these areas will not coordinate 
with copper. 
 
Ac-KKRPKPWGQ(PHGGGWGQ)4GGGTHNQ-NH2 
 
 This peptide model of PrP (23-28, 57-98) consists of 48 amino acids and is expected to 
serve as a good model for the copper binding region of PrP. 
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  Another peptide that was synthesized was the fragment involving the fifth binding site of 
the PrP. It is a 10 mer peptide and had the GGGTH site which has been shown to be involved in 
copper binding. 
 
                                               Ac-WGQGGGTHNQ-NH2  
 
  All the peptides synthesized had tryptophan(s) whose side chain absorbs at 280 nm with a 
known extinction coefficient. This aids in determination of the accurate concentration of the 
synthesized peptides spectrophotometrically. 
 The peptides mentioned above were prepared on a 0.1 mmol scale. The automated 
synthesis started with swelling 0.1 mmoles of Rink Amide MBHA Resin with the solvent DMF 
for 30 minutes. The resin was then deprotected with 20% piperdine in DMF twice for 5 minutes. 
The first amino acid was then coupled using DIEA, HBTU and HOBt. Each coupling step was 
given an hour. After several washings with DMF, the N-terminus of the first amino acid was 
deprotected and thus the coupling and deprotecting steps were repeated till the desired amino 
acids were attached to the growing peptide chain. Once the last amino acid was coupled and 
deprotected, it was acetylated with approximately 2 mL of acetic anhydride for about 30 minutes. 
All the amino acids and reagents used were 4 equivalents excess with regard to the amount of the 
resin used. The Fmoc protected amino acids with the side-chain protecting groups, if applicable, 
used for the synthesis are listed in the table in next page. 
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Table 2.1: List of Fmoc protected amino acids with the side-chain protecting groups. 
 
                                     
                                            
     
 
 At the end of the automated synthesis, the peptide obtained is still attached to the resin. 
The peptide is rinsed with methanol and dichloromethane several times alternatively to get rid of 
any DMF from the synthesis process. It is treated with approximately 8 mL of TFA and 250 µL 
each of water and TIS which act as scavengers to prevent side reactions. This treatment cleaves 
the peptide from the resin and removes all the side chain protecting groups. The entire solution is 
kept aside with intermittent shaking for about 2 hours. The cleaved peptide is treated with ethyl 
ether. The insoluble peptide precipitates out and is separated by centrifugation. 
    
 
 
 
 
 
 Protected amino acid used  Protected amino acid used 
K Fmoc-Lysine (Boc)-OH Q Fmoc-Glutamine(Boc)-OH 
R Fmoc-Arginine (Pbf)-OH H Fmoc-Histidine (trt)-OH 
P Fmoc-Proline-OH N Fmoc-Aspartic acid (trt)-OH 
W Fmoc-Tryptophan (Boc)-OH T Fmoc-Threonine (tBu)-OH 
G Fmoc-Glycine-OH   
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2.3 Peptide Purification 
 The peptide obtained after the cleaving was purified using Reverse Phase High 
Performance Liquid Chromatography (RP-HPLC). A standard non-polar C18 column was used 
and the mobile phases used were acetonitrile and 18 MΩ cm water, both containing 0.1% v/v 
trifluoroacetic acid (TFA). TFA or any acid added helps to improve the chromatographic peak 
shape and also provides a source of protons in LC/MS used to characterize the peptide. At a flow 
rate of 10 mL /minute gradient elution is used to separate the peptides in the crude mixture. A 
gradient of 100% water and 0% ACN to 0% water and 100% ACN was set for a period of 40 
minutes. As seen in the HPLC run below, the peptide peak has atleast two different species 
eluting as shown by the shoulder on the initial part of the peak. During the collection process the 
peptide is collected in two different fractions, one before and other after the shoulder in this case. 
Usually, the fractions collected at a later retention time are purer and are used for experiments. 
At the end of the HPLC runs peptides of high purity are obtained. 
 
 
Figure 2.2: RP-HPLC chromatogram on a preparative column of PrP (23-28, 57-98) 
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2.4 Peptide Characterization 
 The purified peptides thus obtained were characterized using Electrospray Ionization 
(ESI) Quadrapole Time of Flight Mass Spectrometry (MS). ESI-MS allows one to determine if 
the product obtained from a given synthesis has the correct molecular weight. Moreover, this 
method of MS typically does not fragment molecules during the ionization process, so it called a 
‘soft’ ionization technique. Hence, this is a good technique for analysis of peptides and proteins. 
The samples were injected to the ESI with a KD Scientific syringe pump at 250 µL/hr and a 
MCP detector voltage of 2700 V. All conditions were optimized to obtain good signal to noise 
ratio and least amount of fragmentation. The peptides were analyzed in positive ion mode to 
interpret the various charged peaks as shown in figure 2.3. Calculation of the deconvoluted mass 
from the m/z peaks using the formula given below, gives us the observed mass which is 
comparable to the target mass.                                                            
                                                             m/z = (M+nH)/n 
 Thus, ESI-MS is an excellent characterization technique for the peptides in positive mode.  The 
table indicates the target masses of the peptides synthesized for this project. Sample ESI-MS 
spectrum is shown in Figure 2.3. 
Table 2.2: Target and observed masses of the peptides synthesized. 
                                                                            
   
 
 
 
 
Model peptides Target mass Observed mass 
PrP (23-28, 57-98) 4921.3020 Da 4920.8625 Da 
PrP (89-98) 1081.4689 Da 1081.7261Da 
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Figure 2.3: An ESI-MS spectrum of PrP (23-28, 57-98) from RP-HPLC. 
 
  In the above MS, two peaks of +3 and +4 charge state were observed. The average mass 
of the two peaks is 4920.8625 Daltons which is very close to the target mass calculated for the 
PrP peptide (4921.3020). Hence, we know that the peptide synthesized was PrP (23-28,  
57-98).
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Chapter 3: Thermodynamics Studies: Prion Protein Binding at Low Copper Loadings 
 
3.1: Isothermal Titration Calorimetry 
 Biological macromolecular interactions, either protein-protein or protein-ligand, are very 
complex. Understanding the nature of forces that drive or stabilize these interactions is of great 
interest as a combination of structural information with the energetics of binding can provide a 
complete picture of the binding process. A measure of the thermodynamics aids in identifying 
the energetic contributions. The thermodynamics of association are characterized by the 
stoichiometry of the interaction (n), the equilibrium constant (Keq), the free energy (∆G), 
enthalpy (∆H) and entropy of the binding (∆S). Here, isothermal titration calorimetry (ITC) is 
used to obtain the thermodynamics for protein-ligand interactions. ITC is a technique that 
directly measures the heat evolved or absorbed during a biomolecular binding event. ITC is the 
most powerful tool that simultaneously determines all the thermodynamic parameters (n, Keq, 
∆H) in a single experiment. The free energy and the entropy of the binding can be calculated 
once the equilibrium constant and enthalpy are known. 
 
General description of an ITC instrument: 
  An ITC instrument consists of two identical cells made of thermally conducting material. 
The sample cell is filled with the macromolecule and the reference cell with buffer or water 
minus the macromolecule. The ligand is in a syringe and is titrated into the sample cell in precise 
aliquots.  
 
 
  
The two cells are surrounded by an adiabatic jacket which is usually cooled by a circulating 
water bath as shown in the figure 3.1. All through the titration experiment, the components are 
maintained at identical temperatures. Any temperature difference between the two cells is 
detected by means of a thermoelectric device, a sensitive thermocouple or thermopile circuit. A 
second thermoelectric device measures the temperature difference between the cell and the 
jacket. Heaters located on both the cells and the jacket are activated or deactivated when a 
temperature difference is detected. 
 After the entire setup for the experiment is ready, prior to the addition of the ligand, a 
constant power of less than 1 mV is applied to the reference cell. This signal directs the feedback 
circuit to activate the heater located on the sample cell. This represents the baseline signal.  
 
                     
                               Figure 3.1: Schematic diagram of an ITC instrument. 
       During the injection of the ligand from the syringe into the sample cell with the 
macromolecule, heat is evolved or absorbed depending on whether the reaction is exothermic or 
endothermic. For an exothermic reaction as heat is released, the temperature of the sample cell 
               27 
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increases and so the sample cell feedback is deactivated to bring the two cells to the same 
temperature. In the case of endothermic reaction, the sample feedback is activated as the 
temperature of the sample cell is decreased. 
       The power that is required to maintain the reference and sample cell at identical 
temperatures is measured as the raw ITC data. This raw ITC data obtained during the titration, a 
plot of power in µcal/sec as a function of time in seconds, is a series of spikes of heat flow 
depending on the number of injections of the ligand. An endothermic event gives rise to a 
positive peak and an exothermic event gives rise to a negative peak. Integration of the heat flow 
peaks with respect to time gives the total heat in kcal/mole for each injectant which when plotted 
against the molar ratio (ligand/macromolecule) gives us the binding isotherm, as shown in figure 
3.2. Fitting the binding isotherm with an appropriate model gives us the thermodynamic 
parameters of the interaction under study.   
 
                
Figure 3.2: Example of an ITC final figure for an exothermic binding event 
 
Raw Data 
Binding Isotherm 
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3. 2: Choice of Buffer for the ITC Experiments 
 One of the important steps in ITC experiments is the choice of the buffer used for 
preparation of the samples. Both the macromolecule and the ligand need to be in an identical 
buffer to minimize the large heats of dilution produced. Large dilution heats could possibly mask 
the desired observation especially if the binding of the molecules involved is weak. Use of a 
good buffer is very critical in ITC experiments as the ligand needs to be highly soluble and no 
precipitation of either ligand or the macromolecule should take place in the sample cell as this 
may interfere in the heat of the reaction being measured.  For the experiments designed in the 
direction of the research goal, a pH of 7.4 is maintained to be physiologically relevant and also 
because copper binding to the protein is pH dependent. Most buffers are compatible with ITC 
and among the buffers available in the pH range, we chose N-2-(Acetamido)-2-aminoethane 
sulfonic acid (ACES). 
       ACES is a zwitter-ionic buffer with a molecular formula of C4H10N2O4S and molecular 
weight 182.2 g/mol (Figure 3.3).  
 
 
 
 
 
 
 
 
 
 
              Figure 3.3 Structure of N-2-(Acetamido)-2-aminoethane sulfonic acid (ACES) 
 
 
  ACES was developed in 1960’s to provide buffers in the pH range of 6.15 – 8.35 for 
wide applicability to biochemical studies. The useful range of ACES buffer in aqueous solutions 
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is 6.1 - 7.5 which is very apt for the experimental setup in this study. ACES is known to form 
several stable complexes with Cu+2, the metal used in these studies. Formation of any ternary 
complexes has not been reported32. The complex formed depends on the pH of the solution. 
Although ACES can bind Cu+2 in a variety of different ways, this should not interfere with our 
ITC measurements because we will be measuring the total heat produced by the reaction and we 
are not interested in describing all equilibria taking place. Some of the complexes of ACES are 
represented below. 
 
 
Figure 3.4: 1:1complex of ACES and Cu+2 32. 
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Figure 3.5: 2:1complexes of Cu+2 to ACES with different ligating atoms32 
 
 Since ACES can coordinate Cu+2 it should also prevent precipitation of the metal. Two 
separate 7.5 mM solutions of copper chloride and copper sulfate were prepared in ACES and no 
precipitation of the metal was found for a period of 48 hours. The optimum concentration of 
ACES used for the ITC experiments was determined by a set of experiments discussed in the 
later sections. 
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3.3 Initial Considerations and Sample Preparation Methodology 
 All the ITC experiments were performed on a VPP-ITC calorimeter manufactured by 
microcal. Every step involved in these experiments starting from sample preparation to the data 
analysis is very crucial and needs to be handled with extreme care given the sensitivity of the 
technique. A typical ITC experiment involves sample preparation, sample and reference cell 
loading, injection cell loading, experimental and injection parameters and data analysis. 
 
Sample preparation: 
  The initial concentration of the macromolecule and the ligand are very critical and need 
to be determined with high degree of accuracy to get true quantitative data. Ultraviolet-visible 
absorbance measurements were used for concentration determination of the peptides. All metal 
solutions were prepared from a concentrated stock solution. All the peptide models tested had 
trypophan(s) in them and the side chain of this residue has an extinction coefficient of 5690  
M-1cm-1. Hence, an estimation of the concentration of the peptide stock was possible by using 
Beer-Lambert’s law. 
A=Űbc 
In the above equation A- absorbance, Ű- molar absorptivity, b- path length, c- concentration 
  For the initial experiments, Cu+2 was titrated into a solution containing the small 
pentapeptide fragment (HGGGW), the fundamental binding unit of the PrP in the octarepeat 
region. These initial experiments helped us to optimize the parameters and also estimate the 
concentration of ACES buffer to be used. 
  As HGGGW binding to copper is a simple 1:1 binding event, the experiment was 
designed to deliver the copper solution in 32 injections where the molar ratio of copper to 
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HGGGW was 2:1by the end. So, if a 1: 1 binding event occurs, it would produce a titration curve 
with an inflection point at around 16th injection or data point. With this in mind, solutions of the 
peptide and copper were prepared. Initially 0.259 mM of copper solution was prepared in 100 
mM ACES from a 15.65 mM stock solution of copper sulfate in nitric acid and 0.02 mM of the 
HGGGW peptide was prepared in 100 mM ACES at a pH of 7.4. Subsequently, the respective 
concentrations were increased to 0.648 mM copper and 0.05 mM peptide to increase the heat 
evolved in the titration for better data collection. Both the macromolecule (HGGGW peptide) 
and the titrant (copper) solutions were prepared in the same buffer to minimize heat from the 
dilution effect upon titration. The solutions prepared were adjusted to a pH of 7.4 before making 
up the full volume so no dilution occurs. All the solutions were prepared using 18 MΩ cm water. 
18 MΩ cm water is deionized water obtained by using ultrapure mixed resin deionization 
columns and is devoid of particles greater than 0.2 µm. This confirms that no metals, organics or 
impurities are contributed from the water. 
 
Loading the Sample cell, Reference Cell and Injection Syringe: 
 The prepared copper and peptide solutions were filtered using 0.45µm acrodisc filters to 
remove any precipitated material and were degassed to remove any residual air bubbles. About  
1.8 mL’s of solution was required to fill the sample cell.  Excess was removed with a long needle 
glass syringe.  The working volume of the cell (not including the stem) is 1.460 mL. Any excess 
solution in the reservoir was removed from the lip of the sample cell. Once the cell is completely 
filled, several rapid additions of solution help dislodge any residual air bubbles on the sides of 
the cells. The reference cell is usually filled with 18 MΩ cm water and changed on a weekly 
basis. Utmost care is required to fill the cells without introducing air bubbles. This is very 
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important because even the smallest air bubbles in the cell or the syringe can interfere with the 
feedback current. Moreover, air bubbles give rise to poor baselines33. 
 The injection syringe was filled with around 600 µL of the degassed copper solution. 
Filling the injection syringe with titrant solution also requires great care. Once the syringe is 
filled, it needs to be loaded into sample cell. Care was taken to avoid bending the needle during 
this process as some of the titrant may expel into the peptide and thus make the first injection 
unusable. This is the reason why the volume of the first injection is less (2 µL) than the 
subsequent injections and this data point is usually discarded. Minor bending of the syringe also 
leads to poor baselines when the injection apparatus is stirring during the titration. The stirring 
ensures uniform distribution of the injected titrant into the peptide solution. At the end of the 
titration typically 258 µL of the copper will have been added to 1.460 mL of the peptide solution.   
 
Experimental Parameters: 
   The parameters of the titration are input into the software program controlling data acquisition. 
 
Experimental Parameters: 
Cell temperature: 25⁰C 
Jacket temperature 25⁰C 
Number of injections 32 
Reference power 25µcal/sec 
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Injection Parameters: 
Initial Delay 60 sec 
1st aliquot volume 2 µL 
Volume of remaining aliquots 8 µL 
Stirring speed 307 rpm 
Spacing 250 sec 
 
 The stirring speed of 307 rpm ensures good mixing and the spacing of 250 seconds 
between injections ensures that the system reaches equilibrium before the next injection. 
       Each titration is done in triplicate to check reproducibility. Extensive cleaning is done 
between the titrations to ensure integrity of the data obtained from the experiment. 
 
ITC Cleaning Procedure: 
         An extensive cleaning procedure for the peptide models used has been designed after 
several trial and error methods. The peptides used don’t precipitate easily thus avoiding the need 
for harsh cleaning reagents. Firstly, at the end of the titration, solutions from the cell and syringe 
are discarded. The sample cell is soaked in methanol for about 15 min and rinsed several times 
with methanol using a glass syringe to remove any peptide stuck to the walls of the reservoir. To 
remove any traces of the copper metal in the cell and the syringe manual soaking and rinsing is 
done with 0.25 M Ethylenediaminetetraacetic acid (EDTA). After this, a cleaning system is set 
up with vacuum connecting the syringe and the sample cell to a waste bottle. The vacuum flask 
is attached to the vacuum line through a Thermovac. 50 mL of 2% Contrad detergent solution is 
run through this system to ensure complete cleaning of the syringe and the cell. Next, 100 mL of 
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18 MΩ cm water is run to wash away the detergent. The cell alone is cleaned with 400 mL of the 
detergent and 1 L of 18 MΩ cm water. This cleaning procedure is used at the end of every 
triplicate run of the same kind of samples. 
 In between the triplicate runs only manual washing with methanol and, EDTA is done 
followed by 18 MΩ cm water. Detergent is not used. Sometimes, thorough cleaning of the 
reaction cell and syringe is done by soaking it with 10% Contrad solution at 65oC for about an 
hour and cleaned with large amounts of 18 MΩ cm water. A water-water run is performed to 
make sure that the instrument is ready for use.  
 
Blank Titrations: 
 The observed binding isotherm is usually plotted as kilocalories per mole of ligand 
injected and against the molar ratio. The observed heats are apparent heats as they include 
contributions from dilution of the titrant, dilution of the peptide solution and stirring of the 
syringe. Blank titrations are performed to correct for heats of dilution33. Blank titrations are 
performed by titrating the titrant or the metal into the 18 MΩ cm water without the peptide in it 
as 18 MΩ cm is used as a reference in all the experiments performed. For forward ITC titration 
experiments Cu+2 in ACES was titrated into ACES and for reverse titration PrP in ACES was 
titrated into ACES. These titrations are for precise determination of the heats of dilution which 
will be subtracted from the binding isotherm before data analysis33. The blank was subtracted 
only in the case of reverse titration for the data analysis shown in chapter 5. 
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3.4 Initial ITC Experiments 
            To start, the ITC titration experiments were performed on a small pentapeptide 
(macromolecule) and Cu+2 (ligand). This system has been studied in depth and it is known that a 
simple 1: 1 complex is formed as shown below in figure 3.6. 
 
 
Figure 3.6: Diagram representing the 1:1 complex of HGGGW and Cu+2 
 
 Titrating Cu+2 into a sample of the HGGGW peptide solution produced the following 
titration binding isotherms. All the samples were prepared as discussed in section 3.3 in 100 mM 
ACES and the pH was adjusted to 7.4. 
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Figure 3.7: ITC titration of 0.259 mM Cu+2 into 0.02 mM HGGGW peptide (100 mM ACES 
pH7.4 at 250c). 
 
  As seen in the binding isotherm the heat released is close to zero and similar to a buffer 
run and the triplicate runs that were done for checking the reproducibility were not identical. So, 
in order to improve the heats involved in the reaction the concentrations of the Cu+2 and the 
peptide were increased and the isotherm in figure 3.8 was obtained. 
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Figure 3.8:  ITC titration of 0.648 mM Cu+2 into 0.05 mM HGGGW peptide (100 mM ACES 
pH7.4 at 250c). 
 
 Improving the concentrations did not give an improved binding isotherm. The graph from 
these titrations indicated that the expected simple 1:1 complex of the pentapeptide with Cu+2 was 
probably not forming due to the fact that it is a very weak binding event and unable to compete 
with the complexing buffer. To investigate this, some experiments were done by CD. 
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3.5 CD Experiments on the Pentapeptide 
 Due to the unexpected results from the very simple binding process of the pentapetide 
with Cu+2, this was studied by CD. This system was earlier studied by CD using non-complexing 
buffers and the signals are well characterized. CD experiments were performed using the sample 
preparation indicated in section 4.3. All the CD studies discussed in this section were done 
before optimization of the parameters and so there is significant noise in the spectrum. All the 
CD data shown are smoothed using Kaleidagraph. 
 
 
 
Figure 3.9: CD spectrum of for HGGGW in Cu+2 (100 mM ACES, pH 7.4 at 200C) 
 
 According to the previous CD studies indicated in section 4.2 the pentapeptide should 
give characteristic positive bands at 330 nm and 588 nm. Figure 3.9 indicates no such band 
whereas a baseline is observed which indicates that no binding took place. This clearly explains 
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why the ITC binding isotherms showed no significant changes in heat and thus no apparent 
binding. 
           Speculating that this behavior of the peptide is due to high competing nature of the ACES 
buffer, the CD spectrum for the pentapeptide was obtained in non-competing buffer used in our 
lab before, N-ethylmaleimide (NEM).The results are shown in figure 3.10. 
 
 
 
Figure 3.10: CD spectrum for 0.1 mM HGGGW peptide in Cu+2 in 10 mM NEM, pH 7.4 at 200C 
 
 In 10 mM NEM buffer, the pentapeptide showed its characteristic signals at 330 nm and 
588 nm indicating the 1:1 complex was formed.To the solution of the complex formed in the 
experiment in figure 3.10, 100 mM ACES was added. Figure 3.11 shows the spectra of 
HGGGW- Cu+2 before and after addition of 100 mM ACES.   
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Figure 3.11: CD spectrum of indicating HGGGW- Cu+2 before and after addition of 100 mM 
ACES. 
 
         From the spectra it is very clear that, upon addition of the ACES buffer the signal for the 
1:1 complex formed between the HGGGW peptide and the Cu+2 completely diminishes to 
baseline meaning that the ACES snatches Cu+2 from the complex proving the high competition 
offered by ACES. 
         Unfortunately, NEM couldn’t be used for the ITC titrations as one of the main criteria 
was that the copper solutions shouldn’t precipitate. So, the concentration of the ACES buffer was 
reduced to lower concentrations. First 1 mM ACES was used and the characteristic signal at 588 
nm wasn’t still apparent. Despite this, the optimal concentration of ACES was chosen to be 10 
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mM as the metal binding region of PrP binds with a higher affinity than the pentapeptide. Due to 
the high competing nature of ACES in the concentration used we could explore the low copper 
occupancy. All the subsequent CD and ITC experiments used 10 mM ACES buffer solutions. 
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3.6 ITC Studies on the N- Terminal Region of PrP (23- 28, 57-98) 
      After optimization of the buffer concentration (10 mM), experiments were carried out on 
the N- terminal region of the PrP (23- 28, 57-98) which is represented as PrP in this chapter. The 
sample preparation methodology for the Cu+2 – PrP ITC runs is similar to that discussed in 
Section 3.3. Changes in the concentration of the peptide and Cu+2 or experimental parameters 
will be mentioned wherever applicable.       
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Figure 3.12 ITC titration of 0.909 mM Cu+2 into 0.035 mM PrP (10 mM ACES) at pH 7.4 and 
250C 
      After synthesizing the PrP using SPPS, a concentration of 0.035 mM solution was 
prepared in the 10 mM buffer and titrated with a 0.909 mM Cu+2 solution. As Cu+2-PrP was done 
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for the first time on the ITC instrument, an estimate of the heat involved in titration was not 
available. So, for the first experiment, a reference power of 35 µcal/sec was set. Upon titration of 
Cu+2 (in the syringe) into the PrP (in the cell), the ITC graph shown in Figure 3.13 was 
obtained.The experiment was conducted at 25⁰C at a pH above 7. By the end of the 32 injection 
titration, the molar ratio of Cu+2 /PrP was 5.0. From the graph, it is evident that the binding 
process is purely exothermic. Since the initial data points were not reproducible and the 
inflection point is not clear, the concentration of protein was increased. 
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 Figure 3.13: ITC titration of 0.909 mM Cu+2 into 0.07 mM PrP (10 mM ACES) pH 7.4 and 
250C. 
 For the next set of experiments, the PrP concentration was doubled to 0.07 mM to obtain 
better heats of reaction and to focus on the earlier events. In order reduce the noise, the reference 
power was reduced to20 µcal/sec. The Figure 3.14 above represents the ITC titration of 0.909 
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mM Cu+2 into 0.07 mM PrP in 10 mM ACES. This titration experiment was so designed so that 
more data points define the initial part of the titration. By the end of the 32 injection titration the 
system reaches only 2.5 molar ratio. By increasing the concentration of the PrP better data was 
obtained. A slight inflection was observed in the initial part of the titration. Since reproducibility 
was an issue with these experiments the concentration of PrP was increased to 0.1 mM and Cu+2 
was increased to 1.2 mM.  
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Figure 3.14: ITC titration of 1.2 mM Cu+2 into 0.1 mM PrP (10 mM ACES) at pH 7.4 and 250C. 
 In the ITC titration for the data shown above CHELEX-ed water was used instead of 
nanopure water all through the experiment. It was performed at 250C at a pH of 7.5. An 
interesting observation in this plot was the inflection point at around 0.5 molar ratio.  Initially for 
the first few injections the concentration of PrP is high and very little copper is available for 
binding. So, based on the binding at 0.5 molar ratio we hypothesized the reaction below 
occurring initially. Also binding at 0.5 molar may indicate a probability for PrP cross linking at 
low copper levels. 
2PrP + 1Cu      PrP2-Cu 
 
 As seen in the above figures reproducibility of the initial part of the titration is difficult to 
achieve. ∆H is indicative of the total heat involved in the reaction which is the difference in heats 
between the initial and completion points of the binding event. The ∆H value obtained for these 
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three graphs is different. In order to obtain a ∆H for these titrations single injection experiments 
were designed. To measure ∆H by a single injection, requires a c value (defined in the equation 
below) large enough so the experimental intercept on the isotherm intercepts the Y axis very 
close to the true ∆H. Since there will be excess macromolecule in the cell, the experimental heat 
Q will be determined by the amount of ligand injected. 
c = KMtotn 
where K is the binding constant, Mtot is the total macromolecule concentration and n is the 
number of binding sites.  
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Figure 3.15: Single injection run of 0.2 mM Cu+2 into 0.1 mM PrP (10 mM ACES) at pH 7.4 and 
250C. 
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   0.2 mM Cu+2 was titrated into 0.1 mM PrP for the single injection run experiments. It 
was carried out till 6 injections at 250C at pH of 7.4. Two runs of the several runs performed are 
shown in figure 3.15.  Since the data points were scattered we couldn’t determine the ∆H from 
these runs. 
             Later, concatenated runs were done at the peptide concentration of 0.1 mM and copper 
concentration of 1.2 mM. It is evident from the previous set of experiments the PrP is not 
saturated. A concatenated run was planned to reach 5 molar ratio of Cu+2 /PrP also retaining the 
initial part of the titration as it is very crucial. After obtaining the data it was found that PrP 
wasn’t saturated even at 5 molar ratio. This is due to the competition offered by the ACES buffer 
to the peptide.  
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Figure 3.16: Concatenated runs of 1.2 mM Cu+2 into 0.1 mM PrP (10mM ACES) at pH 7.4 and 
250C. 
 
 These 64 injection titration runs were done at 25oC and pH of 7.4. In this case 32 
injections were delivered by the first syringe full of Cu+2 solution into the cell containing PrP, at 
the end of which the syringe was filled again with Cu+2 to deliver the next 32 injections which 
makes a total of 64 injections. These titrations were performed in triplicates for reproducibility as 
shown below. 
 In the concatenated runs shown above the first injection point of 2 µL is discarded. These 
concatenated runs were reproducible and were used for ITC data fitting to obtain the 
thermodynamic parameters. 
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3.7 Reverse Titration of PrP (23- 28, 57-98) into Cu+2 
       After successfully obtaining reproducible ITC titration graphs for the forward titration of 
Cu+2 (in syringe) into PrP (in the cell), reverse titrations of PrP (in syringe) into Cu+2 (in the cell) 
runs were executed. These reverse titration data interpreted along with the forward titration data 
will help find an appropriate model for fitting the data. 
Initial reverse titration data was obtained by titrating 0.75 mM PrP into 0.05 mM Cu+2 at 
250C at pH of 7.45. The sample methodology is similar to the procedure discussed in section 3.3. 
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Figure 3.17: Reverse ITC titration of 0.75 PrP in Cu+2 (10 mM ACES) at pH 7.4 and 250C. 
   The ITC data obtained from this titration did not evolve sufficient heat. Hence the 
concentrations were increased and concatenation runs were executed. 
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Figure 3.18: Concatenated ITC (reverse) titration of 1.5 mM PrP into 0.1 mM Cu+2 
(10 mM ACES) at pH 7.4 and 250C. 
 As seen in the figure 3.18, the reverse titration is exothermic and reproducible. The 
binding isotherm shown above does not include the first injection data point. These two sets of 
data were used for data fitting for an appropriate model. The molar ratio in reverse titration 
indicates the moles of PrP/Cu+2. Overlay of the forward titration over the reverse titration 
showed that the process of PrP- Cu+2 binding is a perfectly reversible process as shown in Figure 
3.19 
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Figure 3.19: Overlay of forward and reverse titration to determine reversibility of the process. 
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3.8 ITC Titrations on WGQGGGTHNQ (10 mer Peptide) 
 ITC titrations were done on the fifth binding site (WGQGGGTHNQ). The 10 mer peptide 
was prepared by SPPS and a solution of concentration of 0.1mM is prepared in 10 mM ACES. 
1.5mM Cu+2 was titrated into 0.1mM WGQGGGTHNQ in 10 mM ACES as shown in the Figure 
3. 20. 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20: ITC titration of 1.5mM Cu+2 into 0.1 mM WGQGGGTHNQ (10mM ACES) at pH 
7.4 and 250C. 
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Experimental parameters: 
Total # of injections     32 
Cell temperature          25OC 
Reference power         15µcal/sec 
Stir speed                     307 
Volume of 1st inj         2 µL 
Volume from 2nd inj   8 µL 
Injection spacing         250 sec 
Initial delay                  60 sec 
 
 The titration data obtained showed some amount of heat in the beginning of the titration 
but quickly reached heat of dilution. The amount of heat evolved during the titration was not 
sufficient enough. The results from this data are inconclusive. 
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Chapter 4: Circular Dichroism Studies on Copper Binding to PrP(23-28, 57-98)  
 
4.1 Circular Dichroism 
      The differential absorption of a circularly polarized light by an optically active molecule 
is referred to as Circular Dichroism (CD). 
 
                                                           ∆Ű =ŰR - ŰL  
In the above equation ŰR is absorbance of right circularly polarized light and ŰL is absorbance of 
right circularly polarized light in the above equation. 
            In a CD experiment, the chiral sample is subjected to equal amounts of right and left-
handed circularly polarized light of a selected wavelength alternately. One of the two 
polarizations is absorbed more than the other because of the asymmetry of the chiral molecule, 
and this wavelength-dependent difference of absorption is measured, yielding the CD spectrum 
of the sample. CD is a very valuable tool with several applications like detection of secondary 
structure of proteins or conformational changes or measurement of ligand binding. Far UV CD 
studies help in identification of the secondary structures of proteins whereas; visible CD 
spectrometry is a powerful tool in investigation of the metal protein interactions. This sensitivity 
of CD spectra to different ligand interactions in a way is used to measure ligand binding in this 
project. The metal of interest is Cu+2, a transition metal. Cu+2 is a d9 species that absorbs in 
visible region due to d-d transitions. These transitions give information about the coordinating 
ligands and the geometry of the molecule. Any changes in the coordination ligand sphere 
involving Cu+2 can be observed as changes in d-d transitions and thus reflected in the CD 
spectrum. CD spectroscopy is very sensitive to changes in these transitions even for molecules 
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with low extinction coefficients. Use of CD spectroscopy for this study has proved to be very 
useful in terms of estimating the different coordination complexes involved during the titration. 
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4.2 Previous Circular Dichroism Studies on PrP(23-28, 57-89)  
      As mentioned in chapter 4.1, CD is used to measure the d-d transitions of Cu+2 in the 
visible region. Any changes in the coordination ligand of Cu+2 leads to changes in the absorbed 
wavelength respectively. Based on these principles of CD, several experiments were performed 
earlier in our lab where signature absorption bands were assigned to certain coordination 
complexes of Cu+2 with the different binding units of PrP. These signature absorption bands can 
be used to characterize the extent and mode of copper PrP binding in the present studies. 
    The PrP peptide (23-28, 57-98) contains 5 binding sites to bind copper as shown below. 
 
KKKRPKPWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHNQ 
 
       Out of the 5 binding sites, typically there are 2 different types of binding sites, the 
octarepeat region (PHGGGWGQ) which repeats 4 times and the GGGTH residues, the fifth 
binding site. The fundamental unit of the octarepeat region is HGGGW and that of the fifth 
binding site is GTH. 
Figure 4. 1 below represents the CD spectra of the fundamental units of Cu+2 binding in the PrP 
peptide when fully loaded with Cu+2.  
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Figure 4.1: CD spectra of GTH binding site and dioctarepeat fully loaded with Cu+2 30. 
 
     The two complexes differ greatly in terms of the coordinating ligands, for which a great 
difference in the λmax associated with these coordination complexes is observed. In this spectrum, 
solutions of WGQGGGTHNQ and WGQPHGGGWGQPHGGGWGQ were prepared in 10 mM 
NEM separately and saturated with Cu+2 and the CD signal for the complex formed was 
obtained. The maximum absorption peaks in the visible region of the two complexes differ by 
about 100 nm. Thus, if the fifth binding site is loaded with Cu+2 it can be identified by CD 
spectrum with λmax of 496 nm and a minimum absorption at 588 nm. Similarly, an octarepeat-
Cu+2 complex gives a maximum absorption at 588 nm. This data is relevant to individual Cu+2 
loaded binding units.  
       Another set of interesting data obtained was the titration curves of the full length Cu+2 
binding region of PrP (residues 57-98). Figure 4.2 is the spectra of a CD titration performed on 
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PrP. Various equivalents of Cu+2 were titrated into a 100 µM PrP (23-28, 57-98) solution in 10 
mM NEM at pH 7.3.  
 
 
Figure 4.2: Titration of PrP (23-28, 57-98) with Cu+2 in NEM buffer30. 
 
    At 0 eq. of Cu+2, where only PrP is present in the solution, no characteristic peaks were 
observed. On addition of Cu+2 peaks appear whose intensity and λ max change consistently with 
consecutive titration points until a saturation point is reached. Information about the secondary 
structure of the PrP peptide was not interpreted from these titrations. The peaks in the UV region 
are due to ligand to metal charge transfer (LMCT) and the peaks in visible region are due to d-d 
transitions in the Cu+2. In this titration some of the evident peaks in the UV region are a negative 
peak at 290 nm and a positive band at 345 nm. These peaks can be correlated to amount of Cu+2 
bound. For the present studies of my project, the area of the interest is the visible region which 
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gives the idea about the environment of the coordination sphere of the Cu+2. It appears from the 
figure 4.2 that in the visible region a positive band with a λmax of 500 nm appears at 1 eq. of Cu+2 
whose intensity increases as more Cu+2 is added. After 1.5 eq. of Cu+2 a shift to longer 
wavelength appears. Upon saturation at around 5 Eq of Cu+2, a positive band centered at around 
530 nm is seen. From this titration experiment, a conclusion was drawn that the dominant mode 
of Cu+2 binding was different at low Cu+2concentration than at higher concentrations. The shift in 
the wavelength at higher concentration indicates that there was a change in the coordination 
sphere of Cu+2. Multivariate Curve Resolution-Alternating Least Squares Analysis was done the 
titration data. Three pure component spectra were identified in the titration data. Comparing the 
pure components to the CD data of fragments (as shown in Figure 4.1) revealed specific Cu+2 
binding structures30. 
     From the characteristic signals seen in figure 4.2, it was estimated that the positive band 
at around 500 nm is comparable to the 498 nm peak of the 5th binding site (figure 4.1). After this 
binding site is completely saturated on addition of Cu+2, the individual octarepeats start to fill. 
This is the reason for the shift of the λmax to higher wavelengths as the octarepeats have higher 
λmax than the 5th binding site when loaded with Cu+2. 
       To summarize the binding events occurring when Cu+2 is titrated into PrP, in each of the 
5 binding sites (four octarepeats and fifth binding site) histidine acts as the anchoring site for the 
copper. Initially, copper coordinates to all or few of the histidines of octarepeats which makes it 
CD inactive as shown in Figure 1.8 in chapter 1. At intermediate Cu2+ occupancy, there is a 
competition between the multiple histidines and the 5th binding site for Cu2+ and the later 
saturates first followed by the octarepeats. 
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4.3 Sample Preparation Methodology 
           The CD titration of Cu+2 was done by two different methods which are described in detail 
in the later part of the section. All the data collected for the Cu+2 titrations were on 100 µM of 
the PrP (23-28, 57-98) in 10 mM ACES. The copper titrated into peptide was prepared from a 
stock of CuSO4 solution in 10 mM ACES. All solutions were first adjusted to pH of 7.4 using 
small amounts of known molarity of sodium hydroxide (NaOH) and then made upto the required 
volume using volumetric flask. 
 
Blank Preparation: 
        A blank solution of 10 mM ACES was prepared in 18 MΩ cm water from a pre-prepared 
stock solution of 0.2 M ACES solution.  
 
Peptide Preparation: 
         The PrP peptide (23-28, 57-98) was synthesized by SPPS, purified and lyophilized. A 
stock solution of this peptide was prepared in 18 MΩ cm water. The concentration of the stock 
solution was determined by using ultra-violet visible spectrometry (UV-Vis) in a 1cm quartz 
cuvette. In the peptide used, 5 tryptophans are present all of which absorb at 280 nm. Trytophan 
has an extinction coefficient of 5690 M-1 cm-1. The exact concentration of the stock solution was 
determined using Beer-Lambert’s Law. 
 
     Copper Solution Preparation: 
       A stock solution of CuSO4 of 15.65 mM concentration was prepared. Various 
concentrations of the copper solutions required for the titration were prepared from the stock 
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solution in 10 mM ACES. The pH was adjusted to about 7.4 using 1M NaOH and HCl and the 
final volume was made up using a volumetric flask. 
 
Optimization of Parameters: 
          CD experiments were performed on a JASCO J-810 spectophotometer. Two matched 
quartz cuvettes of 0.1 cm path length were used for blank and sample solutions. The CD 
instrument is calibrated at regular intervals with a solution of camphor sulfonic acid (CSA). 
Blank runs are performed at the beginning and end of the titration. Obtaining a good blank signal 
is very crucial in these titrations as the signal obtained is weak. Blank subtraction is done by the 
software used in the spectrometer. All the titrations were done at room temperature (200C). The 
sample cuvette used was thoroughly rinsed between runs using methanol, 18 MΩ cm water and 
10 mM ACES to ensure that there were no traces of the copper and peptide from the previous 
sample. The cuvettes are completely dried before use to prevent small but significant dilution 
effects from the buffer used for rinsing.  
   CD experiments were performed as discussed in chapter 3 to determine the concentration 
of the ACES to be used for ITC titrations to keep the peptide at low copper loading state. These 
experiments were performed from 280 to 800 nm, 4 scans and a bandwidth of 2 nm, a scan speed 
of 200 nm/min, a data pitch of 0.1 nm and response speed of 1 sec.                          
             As indicated above, the CD titrations were performed using two methods. In the first 
method, separate solutions of the 100 µM peptide with 1, 2, 5, 10 equivalents of Cu+2 were 
prepared in 10 Mm ACES. Each solution made for the titration was 2.5 ml in volume. The 
solutions were incubated between 4 and 5 hours to ensure maximal Cu+2 loading. For the tiration 
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involving preparation of these individual complexes of copper PrP, the data pitch was 1 nm to 
collect fewer data points and number of scans was increased to 8 to get better data.  
         In the second method, a continuous titration of Cu+2 into the 1.4062 mL of 100 µM 
peptide was performed to reach 5 eq. of Cu+2 at the end of the titration. This method of titration 
was performed to replicate the exact same conditions used in an ITC titration experiment. The 
table 4.3 below lists the steps, quantities of addition of Cu+2 and the molar ratioreached during 
the titration. 
Table 4.1: Calculations for CD titrations 
Eq. of Cu+2 
added 
Vol of Cu+2 
added (mL) 
Total vol added 
(mL) 
Vol in Cuvette 
(mL) 
[PrP] 
(mM) 
[Cu+2] 
(mM) 
Molar 
ratio 
0 0 0 1.4062 0.1 0 0 
1 0.122 0.122 1.5822 0.092 0.09 1.0 
2 0.122 0.244 1.7042 0.086 0.17 2.0 
3 0.122 0.366 1.8262 0.079 0.24 3.0 
4 0.122 0.488 1.9482 0.075 0.30 4.0 
5 0.122 0.610 2.0702 0.070 0.35 5.0 
 
 
       All the calculations shown in table 4.3 are accounted for volume corrections. The dilution 
of the PrP in the cell due to addition of Cu+2 is accounted for in the calculation of the 
concentration of PrP and Cu+2 shown in the table. A 1.2 mM solution CuSO4 was prepared from 
which 0.122 mL aliquots of Cu+2were added to reach a specific molar ratio of Cu+2 / peptide. The 
waiting time for each addition of Cu+2
 
added is around half an hour with vigorous shaking on a 
  
vortex. For these titrations the number of sca
was optimized to 4 nm based on experimental data shown in figure 4.3. The other parameters 
were the same as the previous titration method.
Figure 4.3: CD signal of PrP(23
 
             Another important component of the CD spectrum is High Tension (HT) voltage 
which is a measure of the applied voltage to the detector. In case of low intensity signals in CD, 
the detector increases the volta
detector has been reached or if the voltage rises rapidly, 
signal might not accurately represent the light absorbed by the sample.
 
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
285 335 385
m
D
e
g
. 
65 
ns was increased to 16 and band width parameter 
 
 
-28, 57-98) as a function of bandwidth.
ge to increase the sensitivity. If a value of 400 volts on the 
the CD signal becomes unreliable as the 
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Figure 4.4: HT signal for the 5:1 complex of PrP in 10 mM ACES 
 
        The figure given above is the example of the HT signal data for one of the runs on CD 
and the HT signal for all the CD runs are quite similar to the one shown here. From the graph it 
is clear that the HT is stable between 400 nm to 680 nm and data obtained outside this range is 
unreliable. 
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4.4 Titration of Copper into Native PrP (23-28, 57-98)  
         As discussed earlier native PrP (57-98) is the main copper binding region of the protein 
and has 4 repeats of the octarepeat region PHGGGWGQ and the GGGTH site for copper 
coordination. It binds up to 5 coppers at a pH of 7.4 involving the histidines and the amide bonds 
of the nearby peptide backbone. 
         In the first method of titration as described in earlier chapter, individual solutions of 
various eq. of Cu+2
 
were prepared. The absorption of these solutions was monitored by using CD. 
Figure 4.5 shows the spectrum obtained. 
 
 
Figure 4.5: CD spectrum of titration of 100 µM PrP(23-28,57-98) with Cu+2 (10 mM ACES). 
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             In the CD spectrum collected, the signal obtained is very weak because of the different 
buffer (ACES) used when compare to previous studies done in NEM buffer. ACES is a highly 
competing buffer when compared to NEM. So, the population of copper bound PrP is 
comparatively less and so the intensity of the signal is less. Experiments done to determine this 
have already been discussed in chapter 3.The negative band at 290 nm and the positive band at 
340 nm are due to LMCT and were exactly same in the CD titration observed before expect for 
the intensity difference. At 1 eq. of Cu+2
 
a baseline is seen as the first mode of binding in PrP is 
CD inactive. As the eq. of copper increase to 5 eq. a positive band appears in the visible region at 
500 nm which indicates Cu+2 coordinating to the histidine of the 5th binding site. At 10 Eq. of 
Cu+2
 
the intensity seems to have been decreased. This could possibly be the beginning of loading 
of the individual octarepeats with Cu+2. In the visible region, until 5 Eq of Cu+2
 
all the positive 
bands are centered at 500 nm. As the data becomes very noisy after 590 nm, no conclusions were 
derived from this part of the graph. 
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4.5 Native PrP Titration Data 
         To complement the data from the ITC titrations CD experiments were designed for 
titrating 1, 2, 3, 4, 5 equivalents of copper into PrP peptide. The titration conditions were exactly 
same as the ITC. This was done to have an estimate of the number of Eq. of Cu+2 bound to PrP 
by the end of the titration and also compare the type of Cu+2 coordination that occurs in this 
system when compared to the earlier titrations discussed in chapter 4.2. So, through this titration 
we could confirm the low copper loading state of the peptide and also the stoichiometry of the 
copper PrP binding. This information will aid in for ITC data analysis. In these experiments we 
focused only on the d-d transitions of the Cu+2 in the visible region.  
 
 
 
Figure 4.6: Tiration of the native PrP peptide with Cu+2(10 mM ACES). 
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           As the parameters were optimized the noise was reduced when compared to CD data in 
figure 4.5. The unsmoothed CD spectrum obtained from titration of Cu+2 into the native PrP is 
shown in figure 4.6. Previous CD data showed a λmax of 590 nm for HGGGW Cu+2 coordination 
sphere and a λmax of 500 nm and a minima of 590 nm for GGGTH Cu+2 coordination sphere when 
the peptide is fully copper loaded. Based on this information some conclusions could be made. It 
is evident from the CD data that at 1, 2, 3 eq. of Cu+2 titration into the native PrP there is very 
little signal and they overlap over each other. Initially, a positive band roughly appears at 500 
nm. As more Cu+2 is titrated into the solution an increase in intensity of signal is found but no 
shift in wavelength is observed as expected. At 5 eq. of Cu+2 the system appears to be saturated. 
We hypothesize that only 2:1 molar ratio of copper: prion complex is attained by the end of the 
titration. The 1:1 complex of copper prion is CD inactive and hence not visible in the titration 
and the 2:1 complex produces a CD spectrum with a positive band at approximately 500 nm. 
This wavelength is characteristic for the 5th binding site, GGGTH. Further, individual octrapeat 
binding doesn’t occur as no shift of the λmax occurs which is characteristic for the HGGGGW- 
Cu+2 complex. Based on all these observations it appears that even at 5 Eq of Cu+2 only a 2: 1 
complex is formed. Thus, confirming that the ITC studies are done at low copper loading state as 
per the research goal. 
 
      
 
 
 
 
  
Chapter 5: Data Analysis and Conclusions 
 
 5.1 ITC Data Analysis 
 ITC data analysis is done by fitting the titration data with an appropriate model to obtain 
the thermodynamic parameters. Several software formats are available to fit the ITC data. The 
software used for the purpose of fitting the data was OriginTM. The three common fitting models 
used are ‘one set of sites’, ‘two set of sites’ and ‘sequential binding sites’. In the first case, the 
system is assumed to have n binding sites of equal affinity and in the second case the system is 
assumed to have n1 binding sites of a particular affinity and n2 binding sites with a different 
affinity. Lastly, the sequential binding sites model assumes n sites each with a different affinity. 
 
Binding models used for ‘two sets of sites’ and ‘sequential binding sites’: 
 
Forward Titration: 
Cell      :   PrP  
Syringe:   Cu 
 
 
 
 
 
 
 
 
  
PrP + Cu
K1 PrP-Cu
PrP-Cu + Cu
K2 PrP-Cu2
[PrP-Cu]
[PrP][Cu]
K1 =
 72 
 
Reverse titration: 
Cell      :  Cu 
Syringe:  PrP  
 
 
 
 
 
 
 
 
 
 
 
 
 
β = K1 × K2 = K1’  
K1’ = K1 × K2  
∆H1’ = ∆H1 +∆H2  
 
  All the fitting models evaluate the change in the heat content, ∆Q(i) from completion of 
the ith – 1 injection to completion of the ith injection for a solution contained in the volume V0 . 
Different models have different ∆Q(i) values based on the binding in consideration. 
 
( ) ( 1)
( ) ( ) ( 1)2
i ii
i i i
o
Q QdVQ Q Q
V
−
−
− 
∆ = + − 
 
 
 
∆Q(i) - heat content for the ith injection 
∆Q(i-1) - heat content for the ith-1injection 
PrP + 2Cu
K11 PrP-Cu2
PrP-Cu2 + PrP 2PrP-Cu
K21
K21 =
[PrP-Cu]2
[PrP-Cu2][PrP]
K11 =
[PrP-Cu2]
[PrP] [Cu]2
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V0 - standard active cell volume which is unique to the brand of calorimeter 
      The second term in the above equation is for the displaced volume upon injection of the 
titration. 
    While fitting a model to the ITC data, an initial guess for all the values of n, K and ∆H is 
made. Calculation of ∆Q(i)  is done for each  injection and compared to the experimental fit 
values. The fit parameters are then improved by using a standard Marquadt algorithm. This 
procedure is iterated until Chi2 no longer minimizes. Once the final values of n, K and ∆H are 
obtained the ∆S value is calculated. 
      Fitting of the ITC data was done on the concatenated forward and reverse titrations. In 
the case of the reverse titration since the ligand is in the cell and not in the syringe, this is taken 
into consideration during the fitting. Hence, fitting the data with a correct model should return 
the same thermodynamic parameters for both forward and reverse titration. All the fitting was 
done after removing the first data point and any bad data points due to concatenation of the runs. 
     We started the data fitting with the simplest model, the ‘one set of sites’ model. 
Analyzing the data with this model gave unrealistic n value of less than 0.01and chi2 couldn’t be 
reduced. 
        Using the ‘two set of sites’ model gave a better fit when compared to the one set of sites 
model but the values of the thermodynamic parameters for the two sites were not reproducible 
for the three runs especially the n values and the error values from the Origin software were very 
high.  
 Since, ∆H is indicative of the total heat involved in the reaction which is the difference in 
heats between the initial and completion points of the binding event, an average ∆H value was 
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calculated from 3 most reproducible runs (initial runs with 0.09 mM Cu+2 into 0.07 mM PrP) as 
the single injection runs were not successful. The ∆H (apparent) value for the initial event is  
-2.4x 103 kcal/mole with standard error of 0.1 kcal/mole.  
 
The apparent ∆H value includes the following equilibria: 
 
 
                                                            
 This value was considered as ∆H1 and fixed in the data fitting process to aid in the fitting of the 
parameters but didn’t reduce the errors. 
       Finally, the sequential model with n = 2 was adopted. As the CD titration data that 
complemented the ITC data showed the binding of two coppers, we hypothesize that by the end 
of the ITC titration in 10 mM ACES only 2 binding events occur. Fitting the sequential binding 
model to the forward and reverse titration didn’t provide a good fit to the data. The forward 
titration was not buffer subtracted as the value of heat of dilution is very close to zero but the 
reverse titration was buffer subtracted. 
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Table 5.1: Thermodynamic parameters obtained from forward titration by fitting a sequential 
binding model. 
 
 Thermodynamic  
Parameters Run 1 Run2 
 
Run 3 
K1 1.84 (± 0.22) x 104 1.48 (± 0.19) x 104 1.82 (± 0.31) x 104 
K2 202 (± 33)  139 (± 16)  121 (± 21)  
∆H1 (cal/mol) -3509 (± 162) -4074 (± 218) -3192 (± 204) 
∆H2 (cal/mol) -1.654 (± 0.37) x 104 -4.276 (± 0.62) x 104 -5.242 (± 0.10) x 104 
∆S1 (cal/mol K) 7.75 5.42 8.79 
∆S2 (cal/mol K) -44.9 -134 -166 
 
Table 5.2: Thermodynamic parameters obtained from reverse titration by fitting a sequential 
binding model. 
 Thermodynamic  
Parameters Run 1 Run2 
K1 1.25 (± 0.11) x 103 1.31 (± 0.11) x 104 
K2 1.07 (± 0.09) x 104  1.54 (± 0.13) x 103  
∆H1 (cal/mol) -4509 (± 1040) -6771 (± 120) 
∆H2 (cal/mol) -4.053 (± 0.397) x 104 -4894 (± 191)  
∆S1(cal/mol K)  -0.948 -3.87 
∆S2(cal/mol K)  -177 -1.84 
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    From the above tables, it can be observed the thermodynamic parameters are not 
reproducible in both forward and reverse titration. From the (forward titration) thermodynamic 
parameter values it is evident that K1 is greater than K2 indicating stronger binding for the first 
event.  It also tells us that the second binding event is more exothermic than the first one. For the 
first event since ∆H1 is negative and ∆S1 is positive the reaction is favorable. In the case of 
second binding event, negative ∆S2 probably indicates more order in the system in relative to the 
first event. A trend can be hypothesized from the thermodynamic data for the forward titration. 
The first binding event is both entropically and enthalpically favored whereas the second binding 
event is only enthalpically favored. On the contrary, the first run of the reverse titration shows 
that K2 is greater than K1 which is not consistent with the results from the forward titration. 
Moreover, the K values in the reverse titration differ by an order of magnitude between the two 
runs. 
 It was observed the initial part of the titration curve didn’t have the appropriate fitting as 
the later part of the curve as shown in the diagram 5.1. 
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Figure 5.1: Representative ITC data for the forward titration of Cu+2 into PrP (23-28, 57-98) 
fitted using the sequential binding sites model with n = 2. The best fit parameters are shown at 
the bottom right. 
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Figure 5.2: Representative ITC data for the reverse titration of Cu+2 into PrP (23-28, 57-98) fitted 
using the sequential binding sites model with n = 2. The best fit parameters are shown at the 
bottom right. 
 In order to improve the fitting parameters we hypothesiszed a new binding model which 
may account for the subtle inflection observed at the molar ratio of 0.5 Cu+2: PrP. Before the 1:1 
complex is formed there is a probable existence of another early event at around 0.5:1 of copper 
to PrP. This involves the cross linking of two PrP’s by a single copper. This idea has been 
suggested before through experiments done on BoPrP discussed in the introduction chapter as 
shown in the figure 5.3. 
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Figure 5.3: PrP cross- linking by a single copper ion. 
 
 
New hypothesized binding model: 
                                                            Cu: PrP 
                                              2PrP + 1Cu-----> PrP2-Cu            0.5: 1 
 
 PrP2-Cu + 1Cu----> 2 PrP-Cu          1: 1 
 
                                             2PrP-Cu +2Cu----> 2 Prp-Cu2           2: 1 
                 
           The ITC fitting program needs to be modified in order to fit this binding model and this 
work is currently in progress. 
           In conclusion, from the CD data we conclude that the PrP peptide (57-98) binds only 2 
coppers in 10 mM ACES buffer. Fitting the ITC data with the existing models, i.e one sets of 
sites, two sets of sites or sequential binding, lead to unsatisfactory fits suggesting a more 
complex binding process. The hypothesized model above will hopefully lead to good fits of the 
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ITC data and will support the hypothesis that Cu+2 is cross- linking PrP molecules at low 
equivalents of added Cu+2 . 
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